Talal El Zarif is an Internal Medicine resident in the Physician-Scientist Training Program (PSTP) at Yale University. He grew up in Sidon, Lebanon, and holds a medical degree from the Lebanese University. After graduating from medical school, he joined the lab of Professor Matthew Freedman in the Department of Medical Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center as a post-doctoral research fellow to study cancer epigenomics. During his time there, Dr. El Zarif also led clinical and translational research at the Lank Center of Genitourinary Oncology under the mentorship of Professor Toni Choueiri. His work focused on predictive biomarkers, clinical outcomes, and toxicities of immune checkpoint inhibitors among patients with cancer and has been published in Nature Medicine, Cancer Cell, Journal of Clinical Oncology, European Urology, and others and was presented at several national and international meetings. Dr. El Zarif is a member of the American Society of Clinical Oncology and the American Association for Cancer Research and is interested in a career as a physician-scientist specializing in hematology/oncology.
Education & Training
- Postdoctoral Research FellowDana-Farber Cancer Institute (2023)
- MDLebanese University (2020)